Skip to main content

Quanterix Corporation (QTRX)

NASDAQ: QTRX · IEX Real-Time Price · USD
42.77 0.89 (2.13%)
Dec 8, 2021 4:00 PM EST - Market closed
Market Cap1.57B
Revenue (ttm)106.40M
Net Income (ttm)-47.48M
Shares Out36.65M
EPS (ttm)-0.97
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume348,570
Open41.98
Previous Close41.88
Day's Range40.96 - 43.29
52-Week Range35.02 - 92.57
Beta1.45
AnalystsStrong Buy
Price Target76.00 (+77.7%)
Earnings DateNov 4, 2021

About QTRX

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on...

IndustryLife Sciences Tools & Services
IPO DateDec 7, 2017
Employees314
Stock ExchangeNASDAQ
Ticker SymbolQTRX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for Quanterix stock is "Strong Buy." The 12-month stock price forecast is 76.00, which is an increase of 77.69% from the latest price.

Price Target
$76.00
(77.69% upside)
Analyst Consensus: Strong Buy

News

Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has been r...

3 weeks ago - Business Wire

Quanterix' Simoa® Technology Powers Advances in Alzheimer's Disease Research Presented at 2021 Clinical Trials on Alz...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix' Simoa® Technology Powers Advances in Alzheimer's Disease Research Presented at 2021 Clinical Trials on Alzheimer's Disease Conference

3 weeks ago - Business Wire

Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

3 weeks ago - Business Wire

Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, has announced that David Walt...

1 month ago - Business Wire

Quanterix Corporation Releases Operating Results for Third Quarter of 2021

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced financial res...

1 month ago - Business Wire

Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for

Quanterix Corporation (QTRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021

1 month ago - Business Wire

Why Shares of Quanterix Are Climbing This Morning

Regulators are helping accelerate an early test for Alzheimer's disease.

1 month ago - The Motley Fool

Hot Penny Stocks for Tuesday: Today's 10 Biggest Movers

Penny stocks are on the move Tuesday and we're taking a look at what's hot among traders of the volatile investments today. The post Hot Penny Stocks for Tuesday: Today's 10 Biggest Movers appeared firs...

1 month ago - InvestorPlace

Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer's Disease

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation granted Breakthrough Device designation from FDA for its blood-based pTau-181 assay for Alzheimer's Disease.

1 month ago - Business Wire

Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories

2 months ago - Business Wire

Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test

2 months ago - Business Wire

Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residentia...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a webinar hos...

2 months ago - Business Wire

A Trio of Small Caps for the Growth-Oriented Investor

Investors who are focused on growth could be interested in the following three small-cap stocks, as they represent companies whose trailing 12-month net income per share has improved significantly on a ...

Other symbols:ALEXSTC
3 months ago - GuruFocus

Quanterix Releases Statement

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today released the following statement in res...

3 months ago - Business Wire

Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman and Chief Executive ...

3 months ago - Business Wire

Quanterix Simoa® Technology Powers Breakthrough Alzheimer's Disease Research Presented by Eli Lilly and Company at Al...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Eli Lill...

4 months ago - Business Wire

Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of -3.13% and 7.57%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Quanterix Corporation Releases Operating Results for Second Quarter of 2021

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the thre...

4 months ago - Business Wire

Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its fina...

4 months ago - Business Wire

Will Quanterix Corporation (QTRX) Report Negative Q2 Earnings? What You Should Know

Quanterix Corporation (QTRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Quanterix Appoints Michael Doyle as Chief Financial Officer

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has n...

5 months ago - Business Wire

Quanterix' Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light's Role...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Simo...

6 months ago - Business Wire

Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference a...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Execut...

6 months ago - Business Wire

Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it...

6 months ago - Business Wire